CME | Jotup

Keynote speakers presented Nevisense at the 2024 Winter Clinical Dermatology Conference in Miami

Retrieved on:

Monday, February 19, 2024

Medicine, Skin, SCIB, Dermatology, Life, Conference, Death, CME, Survival, Congress, Melanoma

STOCKHOLM, Feb. 19, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based solutions for skin disorders participated at the 2024 Winter Clinical Dermatology Conference in Miami.

Key Points:

STOCKHOLM, Feb. 19, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based solutions for skin disorders participated at the 2024 Winter Clinical Dermatology Conference in Miami.
The second annual Winter Clinical Miami conference is a 4-day CME course that educates dermatologists on innovative news within Medical, and Surgical Dermatology.
At the conference, SciBase presented its product Nevisense - an AI-powered detection enhancement technology that improves the ability for early detection of melanoma at point of care.
Attendees had the opportunity to learn about Nevisense in the scientific sessions where Nevisense was presented and gain valuable insight on how to improve patient outcomes by integrating Nevisense into their clinical practices.

Annaly Capital Management, Inc. Announces Preferred Dividends

Retrieved on:

Thursday, February 15, 2024

Commercial Building & Real Estate, Construction & Property, Finance, Asset Management, Banking, Professional Services, REIT, Residential Building & Real Estate, CME, Security (finance)

In accordance with the terms of Annaly’s 6.95% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series F Preferred Stock”), the Board has declared a Series F Preferred Stock cash dividend for the first quarter of 2024 of $0.662672 per share of Series F Preferred Stock, which reflects a rate of 10.60275%, equal to three-month CME Term SOFR (plus a spread adjustment of 0.26161%) on the Dividend Determination date plus a spread of 4.993%.

Key Points:

In accordance with the terms of Annaly’s 6.95% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series F Preferred Stock”), the Board has declared a Series F Preferred Stock cash dividend for the first quarter of 2024 of $0.662672 per share of Series F Preferred Stock, which reflects a rate of 10.60275%, equal to three-month CME Term SOFR (plus a spread adjustment of 0.26161%) on the Dividend Determination date plus a spread of 4.993%.
In accordance with the terms of Annaly’s 6.50% Series G Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series G Preferred Stock”), the Board has declared a Series G Preferred Stock cash dividend for the first quarter of 2024 of $0.618152 per share of Series G Preferred Stock, which reflects a rate of 9.78175%, equal to three-month CME Term SOFR (plus a spread adjustment of 0.26161%) on the Dividend Determination date plus a spread of 4.172%.
In accordance with the terms of Annaly’s 6.75% Series I Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series I Preferred Stock”), the Board has declared a Series I Preferred Stock cash dividend for the first quarter of 2024 of $0.421875 per share of Series I Preferred Stock.
Dividends for the Series F Preferred Stock, Series G Preferred Stock, and Series I Preferred Stock are payable on March 28, 2024 to preferred shareholders of record as of March 1, 2024.

Prodapt Appoints Senior Industry Leader Manish Vyas to the Board as Executive Director

Retrieved on:

Wednesday, February 14, 2024

Prodapt, the largest and fastest growing specialized company focused on the Connectedness industry, today announced the appointment of senior industry leader Manish Vyas to the Board as Executive Director.

Key Points:

Prodapt, the largest and fastest growing specialized company focused on the Connectedness industry, today announced the appointment of senior industry leader Manish Vyas to the Board as Executive Director.
View the full release here: https://www.businesswire.com/news/home/20240213734047/en/
Manish Vyas, Executive Director and Board Member, Prodapt (Photo: Business Wire)
With an impressive 23-year tenure at Tech Mahindra, Manish Vyas left an indelible mark as President of the Communications, Media, and Entertainment (CME) business, alongside leadership roles as CEO of Network Services and BPO business units.
In addition, as COO for strategic businesses like Experience Design & Digital Engineering, Manish mentored & provided strategic guidance to drive industry-leading growth.
At Prodapt, Manish will guide the leadership team to drive strategic initiatives, reinforcing Prodapt’s position at the forefront of the industry and propelling its growth trajectory even further.

Mid Coast Health System Accepts National Board of Physicians and Surgeons (NBPAS) to Reduce Physician Burnout and Improve Rural Physician Shortage

Retrieved on:

Tuesday, February 13, 2024

The National Board of Physicians and Surgeons (NBPAS), a non-profit organization providing a streamlined continuous certification pathway for physicians, today announced the acceptance of its continuous board certification program by Mid Coast Health System .

Key Points:

The National Board of Physicians and Surgeons (NBPAS), a non-profit organization providing a streamlined continuous certification pathway for physicians, today announced the acceptance of its continuous board certification program by Mid Coast Health System .
Mid Coast Health System is one of Texas' leading rural statewide healthcare systems, consisting of hospitals, primary and specialty clinics, urgent care, and long-term care facilities across El Campo, Palacios, and Llano.
“As a rural system, we are always looking for ways to increase the number of physicians available to our patients and reduce burnout among our current physicians – NBPAS will allow us to achieve that,” said Thai Huynh, M.D., Chief Medical Officer at Mid Coast Health System.
“We are thrilled that Mid Coast Health System is adding NBPAS as an accepted continuous board certification for its physicians,” said Paul Teirstein, M.D., President of NBPAS.

CME Group Inc. Names Slate of Director Nominees

Retrieved on:

Thursday, February 8, 2024

CHICAGO, Feb. 8, 2024 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today announced its slate of candidates for its board of directors for election at the company's annual meeting to be held Thursday, May 9, 2024.

Key Points:

CHICAGO, Feb. 8, 2024 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today announced its slate of candidates for its board of directors for election at the company's annual meeting to be held Thursday, May 9, 2024.
In addition, the CME Group Nominating and Governance Committee is recommending the following individuals for election by CME Group's Class B shareholders.
CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates , equity indexes , foreign exchange , energy , agricultural products and metals .
In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.

MDpanel Expands Presence, Announces Partnership with Axiom Evaluations

Retrieved on:

Wednesday, February 7, 2024

Partnership, Growth, Axiom, CMLS, Philosophy, Physician, CME, IMes, Insurance, IME

LOS ANGELES, Feb. 7, 2024 /PRNewswire/ -- MDpanel, a provider of expert medical opinions as part of the insurance claims process, welcomes the addition of Axiom Evaluations, a Michigan-based provider of independent medical evaluations ("IMEs"), to its platform.

Key Points:

LOS ANGELES, Feb. 7, 2024 /PRNewswire/ -- MDpanel, a provider of expert medical opinions as part of the insurance claims process, welcomes the addition of Axiom Evaluations, a Michigan-based provider of independent medical evaluations ("IMEs"), to its platform.
The partnership expands MDpanel's geographic presence and product capabilities as it seeks to become the partner of choice for physicians, carriers, attorneys and injured workers.
The partnership with Axiom Evaluations follows the launch of the MDpanel platform in October 2023, which was marked by the combination of the two largest providers of qualified medical evaluations ("QMEs") for workers' compensation claims in California, CMLS, LLC and California Medical Evaluators Holdings, LLC ("CME").
"Partnering with Axiom allows MDpanel to reach more stakeholders in need of quality medical opinions and unlocks new avenues for growth beyond California."

CME Group to Launch U.S. Corporate Bond Index Futures in Summer 2024

Retrieved on:

Tuesday, February 6, 2024

CHICAGO, Feb. 6, 2024 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today announced that its interest rate complex will expand in summer 2024 with the launch of U.S. Corporate Bond Index futures, pending regulatory review.

Key Points:

CHICAGO, Feb. 6, 2024 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today announced that its interest rate complex will expand in summer 2024 with the launch of U.S. Corporate Bond Index futures, pending regulatory review.
"The launch of listed futures on the Bloomberg U.S. Corporate Bond Indices is intended to provide investors with the ability to more accurately and efficiently gain exposure to the corporate bond market and hedge their credit risk."
Available to trade on CME Globex and eligible for submission to clearing via CME ClearPort, U.S. Corporate Bond Index futures will be listed with, and subject to, the rules of a Designated Contract Market at CME Group.
These contracts will also receive automatic margin offsets against existing CME Group Interest Rate and Equity Index futures upon launch.

Inteleos and Credivera Partner to Revolutionize Global Healthcare Credentialing

Retrieved on:

Monday, February 5, 2024

Partnership, ARDMS, Blog, Continuing medical education, Point, Certification, APCA, Patient, Diagnostic medical sonography, Computer, CE, Credentialing, POCUS, Trust, CME, Nursing

ROCKVILLE, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- In a groundbreaking partnership, Inteleos a non-profit global healthcare certification organization, is collaborating with Credivera to transform global healthcare credentialing through the addition of digital identities and verifiable credentials.

Key Points:

ROCKVILLE, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- In a groundbreaking partnership, Inteleos a non-profit global healthcare certification organization, is collaborating with Credivera to transform global healthcare credentialing through the addition of digital identities and verifiable credentials.
The program will address critical issues in the healthcare industry, including fraud prevention and the streamlining of credential verification processes.
The digital wallet can hold a variety of other credentials, with a focus on Inteleos’ collaboration with continuing education (CE) providers.
Inteleos’ partnership with Credivera signals to the certification community that Inteleos is taking a bold step in this direction.

Dynagas LNG Partners LP Declares Cash Distribution on Its Series B Preferred Units

Retrieved on:

Thursday, February 1, 2024

Term, Margin, Partnership, Chicago Mercantile Exchange, Libor, CME, Series, Natural gas, Life insurance

ATHENS, Greece, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (the “Partnership”) (NYSE: DLNG), an owner and operator of liquefied natural gas (“LNG”) carriers, today announced that its Board of Directors has declared a cash distribution of $0.71764025 per unit on its Series B Fixed to Floating Cumulative Redeemable Perpetual Preferred Units (the “Series B Preferred Units”) (NYSE: DLNG PR B) for the period from and including November 22, 2023 to and including February 21, 2024 (the “Distribution Period”).

Key Points:

ATHENS, Greece, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (the “Partnership”) (NYSE: DLNG), an owner and operator of liquefied natural gas (“LNG”) carriers, today announced that its Board of Directors has declared a cash distribution of $0.71764025 per unit on its Series B Fixed to Floating Cumulative Redeemable Perpetual Preferred Units (the “Series B Preferred Units”) (NYSE: DLNG PR B) for the period from and including November 22, 2023 to and including February 21, 2024 (the “Distribution Period”).
The applicable distribution rate for each distribution period is determined every three months by the calculation agent for the Series B Preferred Units.
This is the twenty-first sequential cash distribution on the Series B Preferred Units since they began trading on the NYSE.
The Partnership has 2,200,000 Series B Preferred Units outstanding as of the date of this press release.

CME Group Reports Record January ADV of 25.2 Million Contracts

Retrieved on:

Friday, February 2, 2024

LTD, Financial services, New York Mercantile Exchange, CME Group, City, CBOT, International, Chicago Board of Trade, S&P Dow Jones Indices, NYMEX, OTC, S&P, Metal, COMEX, ADV, Treasury, EBS, CME, Standard

Record January interest rate ADV of 13.1 million contracts, up 27%

Key Points:

Record January interest rate ADV of 13.1 million contracts, up 27%
Record January options ADV of 6.1 million contracts, up 26%
CHICAGO, Feb. 2, 2024 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today reported its January 2024 market statistics, reaching a new overall average daily volume (ADV) record of 25.2 million contracts for the month, up 16% from January 2023.
The company's interest rate ADV saw double-digit growth, driven by its SOFR complex and U.S. Treasury futures.
ADV also increased by double-digits across energy, agricultural and foreign exchange products.
CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates , equity indexes , foreign exchange , energy , agricultural products and metals .